What is Imprivata?
Imprivata is a premier provider of cybersecurity and digital identity software, specifically engineered for organizations operating in mission-critical and highly regulated sectors. The company's platform is designed to streamline access to applications, devices, and sensitive data, addressing the complex challenges faced by healthcare institutions, government agencies, and large-scale enterprise businesses. By focusing on the intersection of security and workforce productivity, Imprivata enables clinicians and employees to access essential systems securely, effectively reducing the friction often associated with robust authentication protocols. Its market position is defined by its deep integration into clinical workflows and its ability to manage privileged access across diverse, complex IT environments.
How much funding has Imprivata raised?
Imprivata has raised a total of $881.9M across 7 funding rounds:
Series A
$13.5M
Series B
$8.9M
Other Financing Round
$12M
Unspecified
$12.5M
Series C
$15M
Stock Offering
$75M
Debt
$745M
Series A (2002): $13.5M with participation from General Catalyst Partners, Highland Capital Partners, and Polaris Partners
Series B (2006): $8.9M led by General Catalyst Partners, Highland Capital Partners, and Polaris Partners
Other Financing Round (2006): $12M supported by General Catalyst and Highland Capital Partners
Unspecified (2007): $12.5M featuring Polaris Partners, General Catalyst Partners, and Highland Capital Partners
Series C (2008): $15M backed by General Catalyst Partners, Highland Capital Partners, Sapphire Ventures, and Polaris Partners
Stock Issuance/Offering (2014): $75M, investors not publicly disclosed
Debt (2020): $745M led by Golub and Goldman Sachs
Key Investors in Imprivata
General Catalyst Partners
A venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors, providing deep operational expertise to help companies scale.
Highland Capital Partners
A venture capital firm that emphasizes a long-term partnership approach, leveraging a track record of over 200 exits to support innovative startups in their growth journey.
Polaris Partners
A venture capital firm specializing in backing transformational companies within the biotech and healthcare sectors, offering extensive coaching and resources for long-term success.
What's next for Imprivata?
With the support of its latest capital infusion, Imprivata is well-positioned to accelerate its product roadmap and expand its footprint in the global cybersecurity market. The company is expected to prioritize the development of advanced identity governance and third-party access management tools, which are increasingly vital as organizations navigate the complexities of hybrid work and digital transformation. By continuing to align its strategic objectives with the evolving needs of healthcare and public sector clients, Imprivata aims to reinforce its status as an indispensable partner for organizations requiring secure, efficient, and compliant access management solutions. The focus remains on scaling operations while maintaining the high-performance standards that have defined its growth to date.
See full Imprivata company page
